GENOME-WIDE AND PATHWAY-SPECIFIC POLYGENIC EFFECTS ON CORTICOSTEROID RESPONSE IN PATIENTS WITH SEVERE INFECTIONS

Le résumé fourni par la source

Introduction: Corticosteroids (CS) improve survival in severe infections, but variable responses have been reported. We aimed to identify genetic variants that could be associated with the differential CS response. Methods: We performed a genome-wide association study (GWAS) of 90day mortality in a cohort of hospitalized COVID-19 patients treated with CS from the SCOURGE consortium (Ncases=375, Ncontrols=1,850). Logistic regression models were conducted in ?9.5M TOPMed-imputed variants (significance set at p=5x10-8). Then, we tested the polygenic overlap of the CS response between COVID-19 and all-cause sepsis using PRSice-2 to perform polygenic risk scores (PRS). The PRS were tested on the independent CS-treated all-cause sepsis patients (Ncases=21, Ncontrols=69) from the GEN-SEP cohort. The best PRS model was subject to pathway-specific PRS studies using PRSet to evaluate which pathways were related to the differential CS response. Results: Three PLCG2 variants, two intronic and one in the 3?-UTR region, were associated with CS response in COVID-19 (plowest=2.79x10?8). A PRS model including 31,374 variants reaching a pthreshold=0.0298 in the GWAS was nominally associated with CS response among all-cause sepsis patients (p=0.044). Pathway-specific PRS analyses revealed the regulation of the cholesterol biosynthesis pathway as the most significantly associated with CS response in all-cause sepsis (p=0.001). Conclusions: Overlapping polygenic effects of the CS response between COVID-19 and all-cause sepsis were observed. Genetic variants affecting the regulation of cholesterol biosynthesis pathway could underlie the CS response differences during critical illness.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.